Back to top

Image: Bigstock

Accelerate Diagnostics (AXDX) in Focus: Stock Moves 6.7% Higher

Read MoreHide Full Article

Accelerate Diagnostics, Inc.(AXDX - Free Report) was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $18.00 to $19.55 in the past one-month time frame.

The company has seen one negative estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few weeks, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Accelerate Diagnostics currently has a Zacks Rank #4 (Sell) while its Earnings ESP is positive.

A better-ranked stock in the Medical sector is IDEXX Laboratories, Inc. (IDXX - Free Report) , which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Is AXDX going up? Or down? Predict to see what others think: Up or Down

Zacks’ Best Private Investment Ideas

While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.

Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors.

Click here for Zacks' private trades >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


IDEXX Laboratories, Inc. (IDXX) - free report >>

Accelerate Diagnostics, Inc. (AXDX) - free report >>

Published in